The Impact of Vaping Ethanol in the Evaluation of Impairment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-02

Study Completion Date

2022-04-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to find out about ethanol-containing e-cigarettes impact ethanol breath tests, field sobriety tests, or other tests of sobriety. Ethanol is a common part of e-cigarette liquids.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Interactive Effects of IV Ethanol and IV Nicotine

NCT01814410

Healthy

COMPLETED EARLY_PHASE1

Computer-Assisted Self-Administration of Ethanol

NCT00713492

Alcoholic Intoxication

COMPLETED PHASE1

Cannabidiol for Alcohol Use Disorder

NCT03904849

Alcohol Use Disorder

WITHDRAWN PHASE1/PHASE2

Effect of Varenicline on Fixed-Dose Alcohol Administration in Participants With Alcohol Use Disorders

NCT01000987

Alcohol Reactivity

COMPLETED PHASE2

Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

NCT01590277

Active Ethanol and Active Iomazenil Active Ethanol and Placebo Iomazenil Placebo Ethanol and Active Iomazenil +4 more

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Electronic Cigarette Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

E-cigarette with ethanol, 1 puff

Group Type EXPERIMENTAL

E-cigarette liquid with ethanol, 1 puff

Intervention Type OTHER

E-cigarette liquid with ethanol, 1 puff

E-cigarette without ethanol, 1 puff

Group Type PLACEBO_COMPARATOR

E-cigarette liquid without ethanol, 1 puff

Intervention Type OTHER

E-cigarette liquid without ethanol, 1 puff

E-cigarette with ethanol, 10 puffs

Group Type EXPERIMENTAL

E-cigarette liquid with ethanol, 10 puffs

Intervention Type OTHER

E-cigarette liquid with ethanol, 10 puffs

E-cigarette without ethanol, 10 puffs

Group Type PLACEBO_COMPARATOR

E-cigarette liquid without ethanol, 10 puffs

Intervention Type OTHER

E-cigarette liquid without ethanol, 10 puffs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

E-cigarette liquid with ethanol, 1 puff

Intervention Type OTHER

E-cigarette liquid without ethanol, 1 puff

Intervention Type OTHER

E-cigarette liquid with ethanol, 10 puffs

Intervention Type OTHER

E-cigarette liquid without ethanol, 10 puffs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals must be e-cigarette users who are 21-65, willing to provide informed consent, attend the lab sessions as needed. Participants must agree to use designated products according to study protocol.

Exclusion Criteria

* Women will be excluded if they are breast-feeding or test positive for pregnancy (by urinalysis) at screening.
* Some study details about the eligibility criteria are purposely omitted at this time to preserve scientific integrity. Full details will be posted at the conclusion of the study.

Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes